Klebsiella pneumoniae producing KPC is a great health concern and therapy with ceftazidime-avibactam represent a choice for the treatment of infections supported by these strains. We report a ceftazidime-avibactam resistant strain by a deletion of 6 nucleotides in the blaKPC gene sequence.
Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime–avibactam due to a deletion in the blaKPC3 gene
Antinori, Elisa;Unali, Ilaria;Bertoncelli, Anna;Mazzariol, Annarita
2020-01-01
Abstract
Klebsiella pneumoniae producing KPC is a great health concern and therapy with ceftazidime-avibactam represent a choice for the treatment of infections supported by these strains. We report a ceftazidime-avibactam resistant strain by a deletion of 6 nucleotides in the blaKPC gene sequence.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
CLINICAL MICROBIOLOGY AND INFECTION 2020.pdf
solo utenti autorizzati
Tipologia:
Versione dell'editore
Licenza:
Copyright dell'editore
Dimensione
380.73 kB
Formato
Adobe PDF
|
380.73 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.